Delivery Order SPE2DB22D1202-SPE2DB25FULD5

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,219.08 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical products. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, SPE2DB22D3004|SPE2DB25FPV43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,716.40 firm-fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, with a completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,581.92 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,602.01 fixed-price delivery order is for the procurement of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a period of performance through March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,898.16 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, to support military healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,721.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF4ED, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,360.42 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, with a performance period running through January 29, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,986.94 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, with a period of performance through July 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,489.17 firm fixed-price delivery order is for the supply of BREYNA 80-4.5 MCG INHALER 10.3GM medical supplies. The contract has an ultimate completion date of January 17, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,413.54 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, with a completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FULD5
    Delivery Order

This federal contract award, with ID SPE2DB22D1202|SPE2DB25FULD5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,888.53 firm-fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product.

The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 1:58 PM